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Background: A ribosomal subunit protein (rsp)-based matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) method was
developed for fast subspecies-level typing of Streptococcus agalactiae (Group B
Streptococcus, GBS), a major cause of neonatal sepsis and meningitis.
Methods: A total of 796 GBS whole genome sequences, covering the genetic diversity
of the global GBS population, were used to in silico predict molecular mass variability
of 28 rsp and to identify unique rsp mass combinations, termed “rsp-profiles”. The
in silico established GBS typing scheme was validated by MALDI-TOF MS analysis of
GBS isolates at two independent research sites in Europe and South East Asia.
Results: We identified in silico 62 rsp-profiles, with the majority (>80%) of the 796
GBS isolates displaying one of the six rsp-profiles 1–6. These dominant rsp-profiles
classify GBS strains in high concordance with the core-genome based phylogenetic
clustering. Validation of our approach by in-house MALDI-TOF MS analysis of 248 GBS
isolates and external analysis of 8 GBS isolates showed that across different laboratories
and MALDI-TOF MS platforms, the 28 rsp were detected reliably in the mass spectra,
allowing assignment of clinical isolates to rsp-profiles at high sensitivity (99%) and
specificity (97%). Our approach distinguishes the major phylogenetic GBS genotypes,
identifies hyper-virulent strains, predicts the probable capsular serotype and surface
protein variants and distinguishes between GBS genotypes of human and animal origin.
Conclusion: We combine the information depth of whole genome sequences with
the highly cost efficient, rapid and robust MALDI-TOF MS approach facilitating high-
throughput, inter-laboratory, large-scale GBS epidemiological and clinical studies based
on pre-defined rsp-profiles.
Keywords: group B Streptococcus, MALDI-TOF, mass spectrometry, ribosomal subunit protein, molecular
epidemiology, bacterial typing
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INTRODUCTION
Streptococcus agalactiae (Group B Streptococcus, GBS), a gram-
positive bacterium colonizing the gastrointestinal and urogenital
tract of around 18% of pregnant women worldwide (Russell
et al., 2017), is a leading cause of neonatal and early infant
sepsis and meningitis. It has been estimated that in 2015, GBS
caused around 90,000 deaths in infants under the age of 3 months
and 57,000 cases of fetal infections/stillbirths (Seale et al., 2017).
The reason for the emergence of GBS as an important human
pathogen has been attributed to the spread of pathogenic GBS
clones (Sørensen et al., 2010) mainly driven by the widely
use of tetracycline, resulting in globally established, genetically
homogeneous GBS lineages in humans (Da Cunha et al., 2014).
In contrast, obligate animal GBS strains, which are often species-
specific, represent an under-researched reservoir of genetically
highly diverse genotypes with zoonotic potential (Fischer et al.,
2013; Godoy et al., 2013).
GBS carry polysaccharide capsules which are main virulence
factors interfering with phagocytic clearance of the bacteria
(Chen et al., 2013). Ten GBS capsular serotypes (Ia, Ib, II,
III, IV, V, VI, VII, VIII, IX) have been described and are
used to classify GBS and to monitor population dynamics
(Slotved et al., 2007). Distinct serotypes are associated with
higher virulence, in particular serotype III, but also serotypes
Ia, Ib and V, which together account for the majority of
invasive disease cases in infants (Seale et al., 2017). Multi-
locus sequence typing (MLST) has also been developed and
applied for GBS discrimination. According to MLST, global
GBS populations are dominated by five major clonal complexes
(CC), namely CC1, CC10, CC17, CC19, and CC23 with CC17,
consisting mainly of serotype III strains, being most pathogenic
(Jones et al., 2003).
Vaccination of pregnant women during the second and
third trimester has been proposed as an approach to prevent
GBS disease in both mothers and infants (Baker et al., 2003).
A trivalent glycoconjugate vaccine, covering serotypes Ia, Ib,
and III has completed phase I and II clinical trials (Heyderman
et al., 2016; Leroux-Roels et al., 2016) and a pentavalent
vaccine including serotypes Ia, Ib, II, III, and V is under
development (Kobayashi et al., 2016). Protein based vaccines
that target surface antigens (pili and alpha-like proteins) are
also developed but they will require to overcome amino
acid sequence variation to induce GBS strain cross-protection
(MinervaX, 2017; Nuccitelli et al., 2011). Consequences of
vaccine deployment on GBS population dynamics needs to be
monitored closely, following possible capsular switches, strain
replacements or emergence of novel GBS strains (Bellais et al.,
2012; Kobayashi et al., 2016).
Matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) has become the gold
standard for high-throughput microbial species identification
in clinical settings (Seng et al., 2009; Singhal et al., 2015).
Commercially available and validated MALDI-TOF MS systems
rely on detection of generic peptide patterns, limiting the
discriminatory power for closely related species and separation
of subspecies (van Belkum et al., 2017; Body et al., 2018).
The conserved ribosomal subunit proteins (rsp) are cytosolic
proteins of high abundance and in the molecular weight range
detectable by commercial MALDI-TOF MS equipment. Whole
genome sequence (WGS) data can be used to in silico predict
molecular masses of distinct rsp. These rsp masses can then be
measured by MALDI-TOF MS, thereby providing a targeted,
biomarker-based approach of classifying mass spectra, superior
to the conventional “pattern-recognition” approach (Suarez
et al., 2013; Ziegler et al., 2015). Here, a highly cost efficient,
rapid and robust rsp-based MALDI-TOF MS GBS typing
approach has been developed that is transferable between
laboratories and enables large-scale GBS epidemiological and
clinical studies.
RESULTS
Capsular Serotype and Sequence Type
Distribution in Global GBS Collection
A total of 796 GBS WGS was collated from public databases
and in-house sequenced isolates from human, camel, bovine
and other animal origin. A listing of the 796 GBS isolates and
their corresponding metadata is provided in Supplementary
Table S1. In silico MLST revealed the presence of 108
sequence types (ST) and except for ST327, all ST that are
among the 28 most abundant in the global population were
present (Supplementary Figure S1). In accordance with the
PubMLST S. agalactiae isolate database (Jolley and Maiden,
2010), ST17, ST1, ST23 and ST19 were the most frequent
ST, accounting for 36% isolates in our collection (50% in
PubMLST). All capsular serotypes, except serotype VII, were
represented with Ia (n = 126), Ib (n = 52), II (n = 211),
III (n = 183), IV (n = 80), V (n = 111), VI (n = 9), VIII
(n = 1), IX (n = 2) and non-type-able (n = 21). In summary,
these 796 WGS constitute a representation of the known
global GBS population.
Genome-Wide Phylogenetic Analysis of
GBS Collection
The evolutionary relationship of these 796 GBS strains was
then assessed by core-genome based phylogenetic analysis.
Sixteen GBS strains originating from Camelus dromedarius
were found distant from all other GBS strains (Figure 1A,
marked as W). Other isolates from fish and frog (Figure 1A,
marked as X) and cattle (Figure 1A, marked as Y) formed
distinct, host origin specific phylogenetic clusters. The other
phylogenetic clusters consisted predominantly of GBS of human
origin, with sporadic presence of animal associated strains.
An exception to this was one distinct phylogenetic cluster
containing strains of bovine, dog, fish, human and rat origin
(Figure 1A, marked as Z).
Core-genome based phylogenetic clustering was also
compared with in silico classification based on MLST.
A total of 108 sequence types (ST) were grouped into 15
clonal complexes (CC) of closely related isolates (CC67,
CC1, CC17, CC23, CC19, CC10, CC459, CC452, CC7,
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FIGURE 1 | Fast Tree phylogenetic tree based on core-genome analysis of 796 Group B Streptococcus whole genome sequences. Individual strains are annotated
with (A) host origin, (B) in silico predicted multi-locus sequence typing clonal complex (CC) or sequence type (ST) and (C) in silico predicted capsular serotype.
(Scale bar: nucleotide substitutions per site). The capital letters in (A) mark phylogenetically distinct clusters of obligate camel (W), fish/frog (X) or cattle (Y) origin and
one heterogeneous cluster (Z) consisting of GBS strains from various hosts.
CC283, CC615, CC609, CC103, CC4, and CC552). A high
agreement between MLST classification of GBS isolates
and the core-genome phylogenetic clustering was obvious
(Figure 1B). As expected, core-genome based classification
provides better resolution, thereby further sub-grouping
genotypes that appear identical by MLST. In some cases,
the genetic variation of such sub-groups puts them into
overall closer phylogenetic relationship with genotypes of
other CC like CC23 and CC452, CC10, CC7 and CC283 or
CC1, CC4 and CC459 (Figure 1B). Comparison of core-
genome phylogenetic clustering with in silico assigned capsular
serotypes confirmed that genotypes clustering together are
likely to share identical capsular serotypes (Figure 1C).
Expression of variants of five GBS surface proteins including
alpha-like protein (Alp) gene family, pilus islands, surface
immunogenic protein (Sip), laminin-binding protein (Lmb)
and Group B Streptococcus immunogenic bacterial adhesin
(BibA) followed largely core-genome based phylogeny
(Supplementary Figure S2).
Assessment of Measurability and
Variability of in silico Predicted
Ribosomal Subunit Protein Molecular
Masses
Whole genome sequence data of 29 GBS isolates available
and cultured under in-house conditions were used to predict
in silico molecular masses of all known 59 rsp. MALDI-TOF
MS analysis conducted with these 29 GBS isolates revealed that
28 rsp were reproducibly measured in a molecular weight range
between 4,425 Da and 19,293 Da (Figure 2A). These experiments
confirmed that our novel sample preparation protocol enabled
us to identify mass variation among 28 distinct rsp (Figure 2B).
Next, the remaining 767 WGS were used to predict in silico
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FIGURE 2 | Continued
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FIGURE 2 | (A) A representative MALDI-TOF mass spectrum of a Streptococcus agalactiae ST7 strain, covering the mass range between 4,000 Da and 22,000 Da.
The arbitrary intensity values of the mass peaks are given on the y-axis. Dashed lines indicate the position of the 28 ribosomal subunit proteins (rsp) targeted in our
analyses. (B) Assessment of mass spectra belonging to five Group B Streptococcus (GBS) isolates confirm in silico predicted mass shifts in three rsp (L35, L13, and
S8). Green: Major rsp mass, yellow and orange: rsp mass variants. (C) In silico predicted molecular mass variation of 28 rsp across 796 GBS whole genome
sequences. Ribosomal subunits proteins are ordered from left to right by increasing molecular weight. Green: Most abundant rsp mass allele; yellow, orange and
blue: 2nd, 3rd, and 4th most abundant rsp mass allele; Red: remaining rsp mass alleles.
molecular masses of these 28 rsp, including S8–S10, S12, S13,
S15–S19 and S21 of the small ribosomal subunit and L6, L13, L14,
L17-L19, L21-L24, L29, L30, and L32-L36 of the large ribosomal
subunit. Three rsp (L14, L29, and S15) did not show allelic mass
variation across all 796 isolates. Four rsp (L22, L32, L33 and S21)
showed a variant mass in 1 out of 796 isolates. Eighteen rsp (L6,
L17-L19, L21, L23, L24, L30, L34, L36, S9, S10, S12, S13, and S16-
S19) showed mass variants in fewer than 8 out of 796 isolates. The
most variable rsp were L13, L35, and S8 displaying mass variation
in > 100 out of 796 isolates (Figure 2C).
Definition of rsp-Profiles in GBS
Collection
Next, we predicted all possible combinations of these 28 rsp
based on the 796 GBS WGS collection. Limited by the MALDI-
TOF MS detection accuracy (400 ppm threshold), 62 unique
combinations of the 28 rsp were identified, which are referred
to as rsp-profiles. Six dominant rsp-profiles (rsp-profiles 1–6),
present in 83 to 134 GBS isolates covered 83% of the isolates
(657/796). Five rsp-profiles (rsp-profiles 7–11) were present in
5 to 42 GBS representing 9% (72/796) of isolates. Rsp-profiles
12–22 existed in 2 to 4 isolates (27/796, 3%) and the remaining
40 rsp-profiles named 23–62 were singletons (40/796, 5%)
(Supplementary Figure S3). Rsp-profiles classified GBS strains
in high concordance with the core-genome based phylogenetic
clustering (Figure 3). GBS strains sharing an identical rsp-profile
were located either next to each other or in the same subordinate
cluster in the core-genome based phylogenetic tree. Exceptions
were one rsp-profile 5 and two rsp-profile 4 strains that were
grouped to strains with different rsp-profiles as well as five ST103
strains with rsp-profile 4 that formed a separate group in the
core-genome analysis (Figure 3). These strains displayed novel,
in silico predicted, rsp-profiles but the molecular mass differences
to rsp-profile 4 and rsp-profile 5, respectively, were undetectable
by our MALDI-TOF MS, highlighting the technical limitations
of the mass spectrometer. GBS strains isolated from camels
displayed a large variety of camel-specific rsp-profiles. Unique,
animal-specific rsp-profiles were also observed in ST260/ST552
strains originating from frogs (n = 1) and fish (n = 3) and in CC67,
ST61, ST591 and ST622 (n = 150) bovine strains (Figure 4 and
Supplementary Table S1).
Co-occurrence of rsp-Profiles With
MLST, Capsular Serotyping and Surface
Protein Expression
We investigated how GBS strains belonging to the six dominant
rsp-profiles compared to in silico predicted MLST based CC
(Figure 5A), capsular serotypes (Figure 5B) and pilus island
variants (Figure 5C) in our GBS collection. We found that
the rsp-profile of a given GBS strain provided a reliable
predictive value regarding its membership to a distinct CC,
expression of capsular serotype and pilus island variants
(Supplementary Table S2).
Whole-Cell Lysate MALDI-TOF MS
Analysis of GBS
A total of 248 GBS isolates were grown and then analyzed in
quadruplicates by MALDI-TOF MS resulting in 992 mass spectra.
Twenty-five rsp were detected in > 98% of all spectra acquired.
L34, L6, and L33 were found in 96, 91 and 80% of mass spectra
acquired, respectively. For the 29 GBS isolates grown in-house
and with WGS available, 14 distinct rsp-profiles, including rsp-
profiles 2–6, 11, 15, 18–22, 37, and 55 were predicted in silico.
Validation by MALDI-TOF MS demonstrated 100% sensitivity,
with all 29 GBS being assigned an rsp-profile (Table 1A). All but
one of the MALDI-TOF MS measured rsp-profiles corresponded
to the in silico predicted rsp-profiles (specificity of 97%). One
isolate, classified as rsp-profile 6, should display the unique rsp-
profile 55 according to in silico prediction. Rsp-profile 55 differs
by an unique mass allele of rsp L32 from rsp-profile 6 and we
cannot exclude the possibility that lack of nucleotide sequence
quality led to dubious in silico prediction of L32.
For 219 GBS isolates without WGS available, rsp-profiles were
assigned to 210/219 isolates (Table 1B). Manual inspection of
the spectra of six unassigned isolates revealed that some rsp
were missed during automated assignment due to poor resolution
of their mass peaks. These rsp were updated accordingly and
the six isolates could subsequently be assigned to an rsp-profile,
producing an overall sensitivity of 99% (216/219 isolates assigned
a rsp-profile). A total of 150 GBS isolates were assigned to the
dominating rsp-profiles 2–6. Of the GBS isolates originating from
cows, five ST591 strains were assigned to rsp-profile 19 and one
strain (SLV ST19) was assigned to rsp-profile 6. Sixty-five isolates
of camelid origin were assigned to seven different rsp-profiles that
are, with exception of rsp-profile 22, specific for camel genotypes.
Three isolates could not be classified because they displayed an
rsp-profile not yet contained in our reference database based on
the 796 WGS collection.
Confirmation of Inter-Laboratory
Reproducibility of Our Method
Matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry typing of eight GBS isolates of fish origin confirmed
that our rsp-based typing method is transferable to other research
sites and MALDI TOF MS equipment. Sample processing
following our protocol and measurement on a Microflex MALDI-
TOF MS produced high quality mass spectra, with all 28 rsp
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FIGURE 3 | FastTree phylogenetic tree based on core-genome analysis of 796 Group B Streptococcus whole genome sequences (WGS). Individual strains are
annotated with their in silico determined ribosomal subunit proteins (rsp)-profile. For simplicity, only the six globally dominant rsp-profiles are shown (covering 83% of
isolates in our WGS collection). Marked with asterisks are eight strains whose rsp-profile was miss-assigned due to limitation of MALDI-TOF MS resolution (i.e.,
400 ppm). (Scale bar: nucleotide substitutions per site).
detected. All isolates were assigned to rsp-profile 5, one of the
global dominant lineages. In silico prediction of the 28 rsp
molecular masses based on the available WGS confirmed the
correct identification for all eight isolates (Table 1A).
DISCUSSION
We have harnessed the advantages of information depth
generated by WGS with the highly cost efficient, rapid
and robust MALDI-TOF MS approach to develop a high-
throughput, biomarker-based typing method for GBS clinical
and epidemiological research. GBS typing methods based on
MLST, pulsed-field gel electrophoresis (PFGE) or capsular
serotyping can provide insight into GBS epidemiology. However,
a significant proportion of non-typeable strains cannot be
identified by capsular serotyping and PFGE results are difficult
to compare across laboratories. These methods are also limited
due to their time-consuming nature, considerable per sample
processing costs and in inferring evolutionary relationships
between strains (Furfaro et al., 2018). MALDI-TOF MS has
become a recent standard for clinical microbiological diagnostics
(Seng et al., 2009; Singhal et al., 2015) and it has been applied to
identify GBS hyper-virulent ST17 and ST1 strains based on single
biomarker masses of either unknown (Lartigue et al., 2011) or
non-rsp identity (Lin et al., 2017).
Rapidly increasing availability of WGS data with development
of computational analysis tools allows now in-depth comparison
of whole bacterial genomes (Tettelin et al., 2005). We used
796 GBS WGS that were representative of the global GBS
population and developed a MALDI-TOF MS based GBS typing
method resting on detection of allelic mass differences of pre-
defined markers. Our approach targets 28 distinct rsp with a
molecular mass between 4,425 Da and 19,293 Da, allowing
us to simultaneously detect molecular mass variation across
a concatenated amino acid sequence of ∼2,700 amino acids.
A refined sample preprocessing protocol was developed enabling
high-throughput analyses of GBS samples yielding high-level
spectra quality. Analysis of one isolate takes less than an hour
and can easily be up-scaled, permitting typing of 40–60 isolates
daily. Our newly developed bioinformatics analysis pipeline
requires minimal bioinformatics knowledge and hands on time
by routine users. Per sample analysis costs < 6 USD renders
our approach highly competitive to currently employed GBS
identification methods.
We identified six dominant rsp-profiles that classify GBS
genotypes in high concordance to their corresponding core-
genome phylogeny (Figure 3). Comparing these six rsp-profiles
against 115,768 MALDI-TOF MS spectra obtained from routine
diagnostic analysis and covering 3,013 bacterial species revealed
that the best matching species following GBS was Streptococcus
pyogenes with only 15/28 rsp detected. This demonstrates
the high specificity and discriminatory power of our rsp-
profile based typing.
One limitation of our method is that only strains with rsp-
profiles deposited in the reference database can be classified
unequivocally. In case of GBS strains with an unknown rsp-
profile, our method will flag these strains for later conduct of
WGS. The in silico extracted novel rsp-profiles can then be
incorporated into an updated reference database for typing of this
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FIGURE 4 | FastTree phylogenetic tree based on core-genome analysis of 796 Group B Streptococcus (GBS) whole genome sequences. Individual GBS strains are
annotated with ribosomal subunit proteins (rsp)-profiles, which are distinct for GBS genotypes of obligate animal origin. Red: rsp-profiles 1, 10, 12, 17, 19, 38, 39,
59, 60, and 61 are exclusively found in bovine isolates. Blue: rsp-profile 49 is unique for fish origin. Rose: rsp-profile 13 is indicative of either fish or frog origin. Khaki:
rsp-profiles 11, 15, 18, 20, 21, and 37 are exclusively found in camel isolates. (Scale bar: nucleotide substitutions per site).
novel strain. Another limitation rests with the inherent technical
capacity of MALDI-TOF MS to discriminate rsp masses. Minimal
molecular weight differences of less than 400 ppm are below
the detection threshold of a routine MALDI-TOF MS machine.
This can lead to failure in distinguishing certain rsp-profiles with
false assignment of rsp-profiles. Future advances in MALDI-TOF
MS technology, improving both accuracy and overall mass range
coverage will help to overcome this.
We propose several possible applications for the rsp-based
MALDI-TOF MS typing method: (i) Identification of hyper
virulent CC17 and CC23 strains and related ST452 (Campisi
et al., 2016). (ii) Tracking of potential zoonotic GBS since most
strains of animal origin display different rsp-profiles than human
GBS strains (rsp-profiles 1, 10, 12, 17, 19, 38, 39, 59, 60, and
61 are confined to bovine origin, rsp-profile 49 is unique for
fish origin, rsp-profile 13 is indicative of either fish or frog
origin and rsp-profiles 11, 15, 18, 20, 21, and 37 are unique
for cameloid origin (Figure 4). (iii) First-line screening for
specific, disease-causing strains as for the GBS disease outbreak in
Singapore affecting adult populations (Kalimuddin et al., 2017).
(iv) Monitoring of post-vaccine introduction impact on GBS
population structure. As learned with the 7-valent and 13-valent
pneumococcal vaccines, the introduction of a glycoconjugate
vaccine targeting only a fraction of circulating serotypes can lead
to the emergence of non-vaccine-type strains associated with
clinical disease (Miller et al., 2011; Weinberger et al., 2011; Devine
et al., 2017). A similar scenario might occur after introduction
of a trivalent GBS glycoconjugate vaccine, highlighting the
importance of large-scale GBS population monitoring. Given
that an assigned rsp-profile provides a robust predictive value
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FIGURE 5 | The global major ribosomal subunit proteins (rsp)-profiles 1–6 provide a probabilistic value regarding the Group B Streptococcus genotypes’ associated
(A) multi locus sequence typing clonal complex (CC), (B) capsular serotype and (C) pilus variants. nt, non-typeable.
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regarding capsular serotype (Figure 5), our method could be used
to monitor if rsp-profiles carrying the vaccine-type serotypes Ia,
Ib, and III vanish over time while other rsp-profiles linked to
non-vaccine-type serotypes increase.
TABLE 1 | Validation of the established ribosomal subunit protein (rsp) typing
scheme with MALDI-TOF MS measurements of in-house group B
Streptococcus (GBS) isolates.
(A) MALDI-TOF MS measurements of 37 isolates with available whole genome
sequence (WGS) data.
n isolates source MALDI
assigned
rsp-profile
in silico
assigned
rsp-profile
n correctly
assigned
3 Human rsp-profile 2 rsp-profile 2 3
1 Human rsp-profile 3 rsp-profile 3 1
1 Human rsp-profile 4 rsp-profile 4 1
3 Human rsp-profile 5 rsp-profile 5 3
1 Human rsp-profile 6 rsp-profile 6 1
5 Camel rsp-profile 11 rsp-profile 11 5
3 Camel rsp-profile 15 rsp-profile 15 3
2 Camel rsp-profile 18 rsp-profile 18 2
2 Bovine rsp-profile 19 rsp-profile 19 2
2 Camel rsp-profile 20 rsp-profile 20 2
2 Camel rsp-profile 21 rsp-profile 21 2
1 Camel rsp-profile 22 rsp-profile 22 1
1 Human rsp-profile 22 rsp-profile 22 1
1 Camel rsp-profile 37 rsp-profile 37 1
1 Human rsp-profile 6 rsp-profile 55 0
8 ∗ Fish rsp-profile 5 rsp-profile 5 8
37/37 assigned (100% sensitivity) specificity:
97%
(36/37)
(B) MALDI-TOF MS measurements of 219 isolates without WGS available.
n assigned source MALDI
assigned
rsp-profile
33 Human rsp-profile 2
16 Human rsp-profile 3
49 Human rsp-profile 4
22 Human rsp-profile 5
30 Human rsp-profile 6
1 Human rsp-profile 7
22 Camel rsp-profile 11
20 Camel rsp-profile 15
17 Camel rsp-profile 18
2 Bovine rsp-profile 19
2 Camel rsp-profile 20
1 Camel rsp-profile 21
1 Camel rsp-profile 37
0 (3)∗∗ Human new profile
216/219 assigned (99% sensitivity)
* Isolates typed in an external laboratory on a different MALDI-TOF MS system.
∗∗Three isolates displayed novel rsp-profiles not yet contained in our
reference database.
In summary, our approach and database is flexible for
inclusion of novel rsp-profiles, robust against inter-laboratory
variation of mass spectra quality, streamlined for easy application
by minimally trained users, suitable for high-throughput, large
scale GBS epidemiological and clinical studies and highly cost
efficient with per sample analysis costs of < 6 USD and results
obtained within minutes.
MATERIALS AND METHODS
GBS WGS Used for in silico Analyses
A total of 876 WGS were obtained on 24-07-2017 from the
National Center for Biotechnology Information (NCBI) genome
database. A subset of 98 WGS was removed from the dataset
since sequence quality did not allow prediction of all 28 rsp
molecular masses. Together with 18 in-house sequenced isolates,
the final dataset consisted of 796 WGS. The dataset contained
data from GBS genotypes isolated over a long time span, with
collection time points dating from 1934 to 2016. The strains
stem from various geographic regions in Africa, the Americas,
Asia, Australia, and Europe. The majority of the strains were
isolated from human (n = 543) or cattle (n = 187), with the
remaining genotypes isolated from fish (n = 25), camel (n = 16),
rat (n = 7), seal (n = 5), dog (n = 4), frog (n = 2), dolphin
(n = 1), or unknown origin (n = 6). Of the strains for which
information of the host health was available, 449 were reported
to be associated with disease, while 277 occurred as non-
disease-causing colonizer. Comprehensive metadata of all WGS
is provided in Supplementary Table S1.
GBS Whole-Genome Sequencing
Genomic DNA was extracted using the QIAamp DSP DNA
minikit (Qiagen, Hilden, Germany). A first batch of three isolates
was processed as described in Rothen et al. (2017). For a
second batch of 15 isolates, paired-end libraries constructed
by the Nextera XT DNA library prep kit (Illumina, San
Diego, CA, United States) were sequenced on a MiSeq system
(Illumina) using a 600-cycle MiSeq reagent kit v3 (Illumina).
De novo assemblies were created using SeqMan NGen from the
Lasergene genomics package version 12.1.0 (DNAStar, Madison,
WI, United States) with standard settings. Comprehensive
WGS information including accession numbers are provided in
Supplementary Table S1.
In silico Prediction of Capsular Serotype
and Multi-Locus Sequence Typing
In silico capsular typing was performed as described by Sheppard
et al. (2016). MLST was carried out using a custom R script,
accessing the query references of the seven housekeeping genes
from the PubMLST database1. Each defined CC consisted of
a founder ST and its single-locus variants (SLV). Remaining
ST that were double-locus variants (DLV) of founder ST were
assigned to the corresponding CC and four ST (ST22, ST26,
1https://pubmlst.org/sagalactiae/
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ST130, and ST616) that could not be attributed to a CC were
defined as stand-alone ST.
In silico Typing of GBS Surface Proteins
tBLASTn analyses were carried out for an in silico variant typing
of five major GBS surface proteins (Supplementary Table S3).
For variant typing of the laminin-binding protein (Lmb) and
the surface immunogenic protein (Sip), one query sequence was
used for BLAST and the identified protein variants assigned an
allele number in decreasing order of frequency. Variant-specific
protein sequences published by Creti et al. (2004) were used as
query files for the alpha-like protein (Alp) gene family. For the
surface protein gbs2018 (BibA), variant-specific query sequences
described by Springman et al. (2009) were used. Distribution of
pilus islands (PIs) types among the WGS was determined using
representative sequences of the three described variants PI-1,
PI-2a, and PI-2b (Martins et al., 2013).
Core-Genome Phylogenetic Analysis
Automatic genome annotation of the WGS was performed with
the Prokka software tool version 1.12 (Seemann, 2014), using
a Streptococcus genus database. The core-genome phylogenetic
relationships of the WGS were obtained using EDGAR version
2.2 (Blom et al., 2016). Briefly, the core-genome was defined
by iterative pairwise comparison of the gene content of each
of the selected genomes using the bidirectional best hits (BBH)
with score ratio values as orthology criterion (Blom et al.,
2016). For all calculations protein BLAST (BLASTp) was used
with BLOSUM62 as similarity matrix (Altschul et al., 1990;
Henikoff and Henikoff, 1992). Multiple alignments of each
of the 867 orthologous gene set of the core genome were
calculated using the MUSCLE software (Edgar, 2004), which
equaled 690,132 genes in total. The resulting alignments were
concatenated to one huge alignment (Talavera and Castresana,
2007), which consisted of 212,086,240 amino acid residues,
266,440 per genome. This alignment was used to construct a
FastTree phylogeny (Price et al., 2009). Phylogenetic trees were
visualized and edited using the interactive tree of life (iTOL)
website (Letunic and Bork, 2016).
In silico Molecular Weight Prediction of
Ribosomal Subunit Proteins
The theoretical monoisotopic molecular weights of rsp were
predicted using an in-house Python bioinformatics pipeline.
Post-translational modifications, specifically N-terminal
methionine loss and methylation, were taken into account.
While a total of 17 rsp (S8-S10, S12, S13, S15, S16, S18, S19,
S21, L6, L17, L21, L22, L30, L32, and L35) were found to display
N-terminal methionine loss, no methylation was observed for
any of the rsp. tBLASTn analyses were carried out for an in silico
typing of the rsp in 796 GBS WGS. Based on the predicted 28
rsp masses in our collection, we assessed the variability of each
mass (mass alleles) and defined unique combinations of mass
alleles (rsp-profiles) across the WGS, taking into account the
MALDI-TOF MS detection threshold of 400 ppm.
GBS Isolates Used for MALDI-TOF MS
Analyses
The 248 GBS isolates used in this study were obtained from four
different sources: (i) 156 human isolates belonging to a set of
S. agalactiae strains described by Huber et al. (2011). These both
inpatient and outpatient samples were obtained and cultivated
at the Aga Khan University Hospital in Nairobi, Kenya between
January 2007 and June 2010; (ii) Seventy-nine samples from the
International Livestock Research Institute (ILRI) isolated from
camels in Kenya and Somalia (Fischer et al., 2013); (iii) Six
GBS samples from cattle, isolated during 2009 in Switzerland
by Prof. J. Frey from the University of Bern (unpublished); (iv)
Seven human GBS reference strains were provided by Dr. H.
Tettelin from the University of Maryland (Tettelin et al., 2005).
More comprehensive information of all analyzed GBS isolates is
provided in Supplementary Table S4.
Bacteria Cultivation and Sample
Preparation
GBS isolates were stored at −80◦C prior to cultivation. After
thawing the isolates on ice, bacterial material was plated on
Columbia Sheep Blood Agar. The plates were then stored at
37◦C in the incubator for overnight cultivation. Single colonies
were transferred to a new agar plate using the four-quadrant
streak method. After repeated overnight cultivation at 37◦C,
S. agalactiae colonies were harvested for sample preparation.
The bacteria material was washed repeatedly in TMA buffer
(10 mM Tris–HCl (pH 7.8), 30 mM NH4Cl, 10 mM MgCl2, and
6 mM 2-mercaptoethanol). In a next step, the bacterial cells were
disrupted using a FastPrep FP120 bead beater in order to lay
open intracellular proteins. To that end, the washed cells were
transferred together with 0.1 mm glass beads to a micro tube.
The mixture was agitated for multiple short time intervals (20s)
at maximum speed, interrupted by cooling intervals (1 min) on
ice. In a last step, protein fragments smaller than 3,000 Dalton
(Da) were removed by filtering of the bacterial extract with
AmiconTM Ultra centrifugal devices. Lastly, the concentrated
sample was mixed with the tenfold volume of ddH2O and 1 µl
of the dilution was applied in quadruplicates on a MALDI-TOF
steel target plate. The spotted samples were left to air dry at room
temperature and consequently overlaid with a matrix consisting
of a saturated solution of 10 mg sinapinic acid in 60% acetonitrile,
40% ddH2O and 1% TFA.
MALDI-TOF MS Analyses
Instrument Setup
The MS measurements were carried out using a MALDI-TOF
Mass Spectrometer Axima Confidence machine (Shimadzu-
Biotech, Kyoto, Japan) with detection in the linear positive mode,
allowing the interrogation of high molecular weight samples.
The acceleration voltage was set by default to 20 kV with an
extraction delay time of 200 ns and a laser frequency of 50 Hz.
The analysis was carried out in the mass range between 4,000
and 25,000 Da. To ensure an even measurement covering the
entire area of the sample spot, a netlike pattern of 100 equally
distributed locations was defined. At each of these profiles ten
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consecutive laser shots were applied, adding up to 1,000 laser
shots per sample spot. The ion gate was set at 3,950 Da and
the pulsed extraction optimized at 20,000 Da. Each target plate
was externally calibrated using the reference spectra of in-house
cultured Escherichia coli strain DH5α.
Mass Spectra Processing and Internal Calibration
The individual mass fingerprints were averaged and the spectra
further processed with the Launchpad 2.8 software (Shimadzu-
Biotech, Kyoto, Japan). The advanced scenario setting was chosen
for peak processing, with a defined peak width of 80 chans,
smoothing filter width of 50 chans and baseline filter width of
500 chans. An adaptive voltage threshold, which roughly followed
the signal noise level, was defined and the threshold offset and
threshold response set to 0.008 and 1.000, respectively. Internal
calibration with 800 ppm was carried out with MALDIquant
(Gibb and Strimmer, 2012), using 10 rsp masses (3 mass alleles
of L6, 2 mass alleles of L36 and S12, 1 mass allele of L14, L29,
and S15) that altogether display mass values distributed over a
wide mass range (4,425–19,293 Da). An ASCII file containing the
recalibrated protein mass values and corresponding intensities
was automatically generated for every mass spectrum.
Classification of Mass Spectra
The mass spectra were classified using a custom Python script
(Supplementary Data Sheet S2). Briefly, all mass spectrum
peaks were queried against the in silico predicted mass alleles
of 28 rsp and the thereby generated sequence of mass alleles
matched against the reference library containing the 62 defined
rsp-profiles. A mass list was assigned an rsp-profile identification
(ID) if (i) there was one single top matching reference and (ii) if
at least 24 rsp masses could be detected. An isolate was assigned
a final rsp-profile ID if (i) at least two of the four technical
replicate mass lists were assigned the same rsp-profile and (ii)
if there was no contradicting match with a different rsp-profile
in the other technical replicate mass lists. If a specific rsp was
missing in all mass lists considered for the final ID of an isolate,
a warning message was generated, indicating the possibility of a
new rsp-profile not yet contained in the database.
Confirmation of Inter-Laboratory Reproducibility of
Our Method
In order to confirm the inter-site transferability and
reproducibility of our method, additional MALDI-TOF MS
analyses were performed in an independent laboratory. Eight
GBS isolates were cultivated and pre-processed following our
established protocol. The MALDI-TOF measurements were
carried out on a Microflex machine (Bruker Daltonics, Bremen,
Germany), with the instrument parameter settings adjusted
for the use of sinapinic acid. Spectra post-processing, internal
calibration, rsp prediction and classification was carried out
in an automated way using our custom R and python scripts
as described above. WGS data of the eight GBS isolates
were available and used in silico to confirm the molecular
masses of the 28 rsp.
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